Ambry Genetics Investors Seek To Block $1B Sale To Konica
Ambry Genetics Corp. investors sought a preliminary injunction late Monday to enjoin the company's $1 billion sale to Konica Minolta Inc., immediately after filing a sealed putative class challenge to the...To view the full article, register now.
Already a subscriber? Click here to view full article